PRAC meeting highlights 27-30 November 2023
27/11/2023
Medicines for human use
Pharmacovigilance risk assessment committee (PRAC)
The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.
The current PRAC highlights from the November 2023 meeting provides further information on PRAC recommendations to minimise the risk of serious side effects with medicines containing pseudoephedrine.